SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-24-001194
Filing Date
2024-02-13
Accepted
2024-02-13 19:43:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 d10977822_13g-a.htm SC 13G/A 160832
  Complete submission text file 0000919574-24-001194.txt   162610
Mailing Address 10275 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91478 | Film No.: 24631207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201
Business Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201 214-550-1822
Avidity Partners Management LP (Filed by) CIK: 0001791827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A